Navigation Links
EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
Date:3/6/2008

er. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. Panzem(R) (2-methoxyestradiol) NCD is also in multiple Phase 2 studies in oncology patients. Additionally, ENMD-1198, a novel tubulin-binding agent, is in Phase 1 studies in advanced cancers. The Company has approved IND applications for Panzem(R) in rheumatoid arthritis, and ENMD-2076, a dual-acting Aurora- angiogenesis inhibitor, for cancer. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation - processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance (including the timing of royalty revenues and future R&D expenditures), strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including risks relating to the need for additional capital and the uncertainty of additional funding; variations in actual sales of Thalomid(R), risks associated with the Company's product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of c
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
2. EntreMed Appoints Senior Vice President of Research and Development
3. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
4. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
5. EntreMed to Present at BIO CEO and Investor Conference
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. QMed, Inc. Reports July Medicare SNP Enrollments
8. Phlo Affiliate Reports Expanded Coverage to Oregon Border
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Carrington Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... YORK , Aug. 27, 2014 ... is available in its catalogue: Global ... http://www.reportlinker.com/p02316662/Global-Chelating-Agents-Market-2014-2018.html About Chelating Agent A ... form covalent bonds with metal ions, thereby forming ... that some metal-ions have on chemical processes, formulations, ...
(Date:8/27/2014)... 2014 “We are honored to be ... Ven Thangaraj, CEO of Radiant Sage. “We are offering ... the imaging corelab market to a different level. ... organizations to efficiently and effectively manage the massive amounts ... be analyzed and read by trained physicians. Being recognized ...
(Date:8/27/2014)... , Aug. 27, 2014 Research and ... "Global Enzyme for Pulp & Paper Industry Report 2014" ... Global Enzyme for Pulp & Paper Industry Report 2014 ... state of the global enzyme for pulp & paper ... of the industry including definitions, classifications, applications and industry ...
(Date:8/27/2014)... Florida (PRWEB) August 27, 2014 ... (SCI) is announcing the creation of the Sancilio ... to take the SCI’s philosophy of looking to ... research and development actions are based on sound ... new Scientific Advisory Board provides a vehicle for ...
Breaking Biology Technology:Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Global Enzyme for Pulp & Paper Industry Report 2014 2New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3
... , CRACKS AMAZON.COM BEST SELLER LIST IN ... of top ten best selling science books , SEATTLE, Nov. ... a new book about the controversial theory of intelligent design made ... just as the world marks 150 years since Charles Darwin published ...
... ... Prospects Forum breakfast series serves as a vehicle to educate investors and the greater ... capital markets. , ... New York, NY (PRWEB) November 17, 2009 -- China Business Knowledge (CBK) ( www.chinabusinessknowledge.com ...
... CORALVILLE, Iowa, Nov. 17 Vivakor, Inc. (OTC Bulletin Board: ... dividend of shares of common stock of HealthAmerica, Inc., a ... outstanding common stock. Each Vivakor shareholder will be entitled ... share of Vivakor common stock beneficially owned on the record ...
Cached Biology Technology:Intelligent Design Book Delivers Blow to Darwin 2China Business Knowledge Launches “China Prospects Forum” -- Dec. 9, 2009, New York City 2Vivakor, Inc. Announces Stock Dividend 2Vivakor, Inc. Announces Stock Dividend 3Vivakor, Inc. Announces Stock Dividend 4
(Date:8/27/2014)... requires nerve cells to rearrange existing patterns of activity ... patterns, a study of monkeys has found. The scientists ... electrical activity of brain cell networks. The study was ... "We looked into the brain and may have seen ... said Aaron Batista, Ph.D., an assistant professor at the ...
(Date:8/27/2014)... By manipulating neural circuits in the brain of ... specific memories. The research, led by Howard Hughes ... Institute of Technology (MIT), reveals that the connections ... contextual information about an experience and the part ... of that experience are malleable. , Altering ...
(Date:8/27/2014)... 27, 2014 University of Utah biologist agan Sekercioglu, ... has won that nation,s highest science prize, which is ... Sekercioglu is among five researchers picked for 2014 the ... Council of Turkey. Three researchers won the Science Award ... Award, which is equivalent to the Science Award but ...
Breaking Biology News(10 mins):Scientists plug into a learning brain 2Scientists plug into a learning brain 3Researchers change the emotional association of memories 2Researchers change the emotional association of memories 3Researchers change the emotional association of memories 4University of Utah biologist wins Turkey's top science prize 2
... A new study released today in the EarlyView of ... Alaska, highlighting a shift in biomes caused by a ... Woods Hole Research Center and three other institutions based ... extensive and unique tree-ring data set. Patterns observed support ...
... Denmark revealed that increasing levels of non-fasting triglycerides are ... men and women. Higher cholesterol levels were associated with ... novel, 33-year study are now available online in ... on behalf of the American Neurological Association. ...
... successfully being used in clinical trials to treat patients with ... die, it also forces them to release pro-inflammatory chemokines and ... attack the disease. New research published by BioMed Central,s open ... infected cancer cells secrete proteins which, even when isolated, result ...
Cached Biology News:New study illustrates shifting biomes in Alaska 2Increasing triglyceride levels linked to greater stroke risk 2
... The ImageXpressULTRA imaging system ... true point-scanning confocal system for automated ... high throughput cell-based screening. ImageXpressULTRA ... software solution for screening acquisition, image ...
... Assay is an anchorage-independent growth assay in ... stringent assay for detecting malignant transformation of ... with carcinogens or carcinogen inhibitors) are cultured ... for 21-28 days. Following this incubation ...
... The BD CARV II Confocal Imager ... an easy to use and cost effective ... microscope. High speed multi-point confocal scanning, combined ... photobleaching and allows real-time imaging and recording ...
... Gels easier and more efficient by providing ... types of pre-cut pre-assembled membrane/filter paper sandwiches ... cm E-PAGE Gels*. The available nitrocellulose and ... transfer of proteins (Figure 1 Table 1). ...
Biology Products: